AI tools for deal sourcing in PE and VC: a practitioner's guide

Half of private capital firms now rank deal sourcing as their number one priority, with AI use for investment decisions more than doubling in a single year, from 13% to 28%. The question is no longer whether to adopt AI for sourcing. The question is which tools, in what combination, and whether the outputs actually hold up under scrutiny.

In conversations with investment teams across Europe, we hear the same frustration: the market is fragmented, platform marketing overpromises, and it is difficult to separate genuine workflow gains from what looks impressive in an initial evaluation. The gap between what a tool shows you and what it delivers once your team is using it daily is wider than most providers acknowledge.

This guide maps the AI deal sourcing market as it stands in early 2026. We focus on what each tool actually does, where it falls short, and what practitioners report after months of daily use.

The market has shifted: consolidation meets specialisation

The most significant structural change in 2025 was Datasite's triple acquisition of Grata, SourceScrub, and Blueflame AI. The combined platform layers Grata's 19 million AI-indexed company profiles with SourceScrub's 16 million expert-verified profiles and 800+ human analysts, creating the largest company discovery dataset in the market. According to Chief Product Officer Doug Cullen, AI tools across the platform have reduced deal execution time by 49 days. For firms already on Datasite data rooms, that matters.

But consolidation carries execution risk. Integrating three acquisitions while maintaining product velocity is historically difficult in enterprise software. And in the meantime, a generation of purpose-built AI sourcing tools has raised significant capital and carved out defensible positions.

Purpose-built AI sourcing tools: where the innovation is

Inven is a Helsinki-based platform covering what it claims is 21 to 28 million company profiles across 160+ countries, with a natural language search interface that lets deal teams describe an investment thesis in plain language and receive matched targets. For European PE specifically, it offers intent-to-sell signal detection and generational handover identification, relevant in markets where ownership transitions drive a significant share of deal flow. The caveat: raw results still require significant manual screening. Revenue estimates and company data can be unreliable, particularly for US-based targets, and deal teams should expect to verify and clean up lists before acting on them. Inven accelerates the discovery phase but does not replace the analyst judgment that turns a long list into a short list.

Raylu positions itself beyond sourcing into what it calls "deal engineering," covering the full arc from thesis to booked founder meetings. The platform generates market maps, enriches companies with AI-generated data points, identifies verified decision-makers, and launches personalised outreach in the firm's voice. The end-to-end approach means fewer handoffs between tools, though it also means committing more of the sourcing workflow to a single platform. The genuine differentiator is speed: Raylu claims to generate thesis-to-market maps in under 30 minutes with 200+ signals per company, which if it holds up in practice, collapses what typically takes an analyst days into a single session.

Specter is worth watching for its predictive signal layer. The platform tracks revenue signals from social posts and filings, talent signals from executive moves, and a proprietary "interest signal" capability that monitors investor activity to predict deals before they are announced. Clients include Bessemer, Index Ventures, Goldman Sachs, and NVIDIA. The VC lean is deliberate. PE firms evaluating Specter should assess whether its early-stage signal strength translates to their deal size.

Valu8 remains the workhorse for Nordic and broader European PE. Founded in 2011, the platform covers European companies across 51 countries with 900+ selectable search parameters and deep ownership data. Valu8's AI features (similarity scoring, NLP classification) are less sophisticated than newer competitors, but its data depth in European markets is difficult to match. Strategic partnerships with data orchestration platforms mean firms can layer AI intelligence on top of Valu8's European data.

CarriedAI takes a different approach entirely: rather than discovering companies, it screens and enriches incoming deal flow. The EU-based platform's AI agents integrate with Affinity and Attio CRMs to automate deal scoring against fund thesis, competitor analysis, and anti-portfolio monitoring: tracking rejected companies for missed opportunities. The trade-off: CarriedAI is a screening agent, not a discovery engine. Firms that need proactive company identification will need to pair it with a discovery tool.

Revi is a hybrid AI and human M&A origination platform that combines automated screening with human analysts to surface and validate opportunities. In our conversations with PE teams, data accuracy and irrelevant company matches have come up as recurring concerns. The platform is still early-stage, and the quality may improve, but it is worth trialling carefully before committing.

Harmonic.ai has the strongest position in VC-specific founder discovery, claiming to track millions of startups and professional profiles refreshed daily. Users include a16z, Accel, and Greylock. For VC firms, Harmonic fills a gap no PE-focused tool covers: identifying founders before they raise.

How incumbents are adding AI layers

The consistent pattern among incumbents: they excel at analysis of known entities but remain weaker at proactive discovery of obscure lower-middle-market companies.

PitchBook's Navigator (launched November 2025) adds natural language queries across its private company dataset. S&P Capital IQ Pro added Natural Language Screening. Gain.pro offers the deepest analyst-verified European PE data with 200+ human analysts. Mergermarket's 600+ investigative journalists still provide exclusive deal intelligence that AI tools cannot replicate. That discovery gap is where the purpose-built tools are concentrating.

Three patterns from practice

The stack question matters more than the tool question. No single tool covers discovery, enrichment, screening, and outreach. The most effective teams layer a discovery engine (Inven, Grata) with a data orchestration layer and a screening agent (CarriedAI or CRM-native tools).

The market is young. Build for flexibility, not loyalty. Most of these tools are Series A or earlier. Some will consolidate, some will disappear. The teams doing this well treat their sourcing stack as modular: easy to swap one layer without rebuilding the whole workflow. Lock-in is the hidden risk in a market moving this fast.

Human judgment remains the bottleneck and the advantage. Every tool in this guide surfaces opportunities. None of them replace the call on whether a deal is worth pursuing. The firms getting the most from AI sourcing are the ones that have built real workflows around the output: dedicated time to review, clear criteria for what gets escalated, and honest feedback loops on what the tools actually catch versus what they miss. Platform metrics tell you what is possible. How your team actually uses the output is what determines value.

---

At Routine Labs, we build custom AI workflows for PE and VC funds, designed around how your team actually works.